Heron Therapeutics (HRTX) PT Lowered to $10 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Serge Belanger lowered the price target on Heron Therapeutics (NASDAQ: HRTX) to $10.00 (from $14.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
